FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (51)AstraZeneca to showcase Phase III data at ASCO 2026
Preheader (138)AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026
Arial
Text Analysis
Body Words144
Subject Words9
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px734 px
X-Spam Score-0.5
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeOvernight
